Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Filing Details / Description
Initmation of Schedule of Analyst/ Institutional Investor Meetings